198 related articles for article (PubMed ID: 12056503)
1. Bradykinin as a major endogenous regulator of endothelial function.
Gryglewski RJ; Uracz W; Chłopicki S; Marcinkiewicz E
Pediatr Pathol Mol Med; 2002; 21(3):279-90. PubMed ID: 12056503
[TBL] [Abstract][Full Text] [Related]
2. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of angiotensin-converting enzyme inhibitor induced thrombolysis in Wistar rats.
Gryglewski RJ; Swies J; Uracz W; Chłopicki S; Marcinkiewicz E
Thromb Res; 2003 Jun; 110(5-6):323-9. PubMed ID: 14592556
[TBL] [Abstract][Full Text] [Related]
4. In vivo endothelial interaction between ACE and COX inhibitors.
Gryglewski RJ; Chlopicki S; Swies J
Prostaglandins Leukot Essent Fatty Acids; 2005 Feb; 72(2):129-31. PubMed ID: 15626595
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin down-regulates, whereas arginine analogs up-regulates, endothelial nitric-oxide synthase expression in coronary endothelial cells.
Vaziri ND; Ding Y; Ni Z; Barton CH
J Pharmacol Exp Ther; 2005 Apr; 313(1):121-6. PubMed ID: 15640399
[TBL] [Abstract][Full Text] [Related]
7. Endothelial nitric oxide, prostacyclin (PGI2) and tissue plasminogen activator (t-PA): alliance or neutrality?
Gryglewski RJ
Pol J Pharmacol; 1995; 47(5):467-72. PubMed ID: 8868142
[TBL] [Abstract][Full Text] [Related]
8. Desensitization of endothelial nitric oxide synthase by receptor agonists.
Wagner S; Groschner K; Mayer B; Schmidt K
Biochem J; 2002 Jun; 364(Pt 3):863-8. PubMed ID: 12049652
[TBL] [Abstract][Full Text] [Related]
9. Modulation of nitric oxide and 6-keto-prostaglandin F(1alpha) production in bovine aortic endothelial cells by conjugated linoleic acid.
Coen P; Cummins P; Birney Y; Devery R; Cahill P
Endothelium; 2004; 11(3-4):211-20. PubMed ID: 15370299
[TBL] [Abstract][Full Text] [Related]
10. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
[TBL] [Abstract][Full Text] [Related]
11. B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects.
Morbidelli L; Parenti A; Giovannelli L; Granger HJ; Ledda F; Ziche M
Br J Pharmacol; 1998 Jul; 124(6):1286-92. PubMed ID: 9720802
[TBL] [Abstract][Full Text] [Related]
12. Enhanced bradykinin-stimulated prostaglandin release in the acutely inflamed guinea pig gallbladder is due to new synthesis of cyclooxygenase 1 and prostacyclin synthase.
Bogar LJ; Bartula LL; Parkman HP; Myers SI
J Surg Res; 1999 Jun; 84(1):71-6. PubMed ID: 10334892
[TBL] [Abstract][Full Text] [Related]
13. Characterization and function of bradykinin receptors in vascular endothelial cells.
Sung CP; Arleth AJ; Shikano K; Berkowitz BA
J Pharmacol Exp Ther; 1988 Oct; 247(1):8-13. PubMed ID: 2902216
[TBL] [Abstract][Full Text] [Related]
14. Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands.
Ignjatovic T; Stanisavljevic S; Brovkovych V; Skidgel RA; Erdös EG
Mol Pharmacol; 2004 Nov; 66(5):1310-6. PubMed ID: 15304551
[TBL] [Abstract][Full Text] [Related]
15. Large-conductance K+ channel opener CGS7184 as a regulator of endothelial cell function.
Wrzosek A; Łukasiak A; Gwóźdź P; Malińska D; Kozlovski VI; Szewczyk A; Chlopicki S; Dołowy K
Eur J Pharmacol; 2009 Jan; 602(1):105-11. PubMed ID: 19028489
[TBL] [Abstract][Full Text] [Related]
16. The long-term exposure of rat cultured dorsal root ganglion cells to bradykinin induced the release of prostaglandin E2 by the activation of cyclooxygenase-2.
Inoue A; Iwasa M; Nishikura Y; Ogawa S; Nakasuka A; Nakata Y
Neurosci Lett; 2006 Jul; 401(3):242-7. PubMed ID: 16580130
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide.
Landmesser U; Drexler H
J Hypertens Suppl; 2006 Mar; 24(1):S39-43. PubMed ID: 16601572
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide: inhibitory effects on endothelial cell calcium signaling, prostaglandin I2 production and nitric oxide synthase expression.
Takeuchi K; Watanabe H; Tran QK; Ozeki M; Sumi D; Hayashi T; Iguchi A; Ignarro LJ; Ohashi K; Hayashi H
Cardiovasc Res; 2004 Apr; 62(1):194-201. PubMed ID: 15023566
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin induces the expression of bradykinin type 2 receptors in cultured human coronary artery endothelial cells.
Liesmaa I; Kokkonen JO; Kovanen PT; Lindstedt KA
J Mol Cell Cardiol; 2007 Nov; 43(5):593-600. PubMed ID: 17900611
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress.
Virdis A; Colucci R; Fornai M; Blandizzi C; Duranti E; Pinto S; Bernardini N; Segnani C; Antonioli L; Taddei S; Salvetti A; Del Tacca M
J Pharmacol Exp Ther; 2005 Mar; 312(3):945-53. PubMed ID: 15547110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
